Company intelligence / Profile preview

Human Longevity

San Diego, California, USAhumanlongevity.com ↗

Ownership: Private
Development stage: Commercial

Overview

Human Longevity's primary commercial activity is diagnostics and preventive health, centered on its Health Nucleus platform for early detection and risk prediction of age-related diseases. Its drug development pipeline is in preclinical stages, with programs targeting conditions like ALS and muscular atrophy.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Synthetic peptideCell therapyDiagnostic platformGenomic sequencing
Industry: Biotech

Partnerships

CelgeneAstraZeneca

Beyond the preview

Go deeper on Human Longevity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Longevity.

Explore the full profile